Next Article in Journal
Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis
Previous Article in Journal
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
Previous Article in Special Issue
(20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells
 
 
Review
Peer-Review Record

It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?

Int. J. Mol. Sci. 2021, 22(24), 13424; https://doi.org/10.3390/ijms222413424
by Giovanni Tarantino 1, Clara Balsano 2,*, Silvano Junior Santini 2, Giovanni Brienza 2, Irma Clemente 2, Benedetta Cosimini 2 and Gaia Sinatti 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(24), 13424; https://doi.org/10.3390/ijms222413424
Submission received: 25 November 2021 / Revised: 11 December 2021 / Accepted: 12 December 2021 / Published: 14 December 2021
(This article belongs to the Special Issue Natural Organic Compounds: Cellular Pathways and Effects)

Round 1

Reviewer 1 Report

Congratulations first of all for the team work! You did a great job.

However I want to make some remarks:

-you have in keywords "nutraceutics and RCTs (randomised controlled trial)" I don't saw this in your abstract. You may insert them.

-on figure 1 correct in nutraceutics target

-line 94 - put after mithocondrial DNA (mtDNA)

-line 98 -put comma after "Moreover"

-line 163 put after cardiovascular (CV) because you used CV diseases in line 384

-insert please all abbreviations in text (for ex. ATP, TNF, RCT, CV)

- I don't see the author contributions at the end - please do that.

 

 

Author Response

Reviewer #1: you have in keywords "nutraceutics and RCTs (randomized controlled trial)" I don't saw this in your abstract. You may insert them.

We thank Reviewer #1 for his/her suggestions. We have modified the abstract as suggested.

Reviewer #1: on figure 1 correct in nutraceutics target

The Figure has been changed as suggested by reviewer 1

Reviewer #1: line 94 - put after mithocondrial DNA (mtDNA); -line 98 put comma after “Moreover”; line 163 put after cardiovascular (CV) because you used CV diseases in line 384; -insert please all abbreviations in text (for ex. ATP, TNF, RCT, CV);

We thank Reviewer #1 all the typing errors and abbreviations have been amended

Reviewer #1:  I don't see the author contributions at the end - please do that.

We thank Reviewer #1, at pag. 10 we enclosed author contribution

As suggested, we have rewritten/refreshed sentences in the manuscript that showed high similarity index with other publications after the Duplicate Checking Process.

All the revised sentences in the manuscript have been made using the “Track Changes” function of MS Word.

 

Reviewer 2 Report

The review article is very-well designed, the figure helps the understanding, and the tables provide wide information about the efficacy of natural products related to NAFLD. 

Author Response

Reviewer #2:  The review article is very-well designed, the figure helps the understanding, and the tables provide wide information about the efficacy of natural products related to NAFLD.

We thank Reviewer #2 for the flattering comments

As suggested, we have rewritten/refreshed sentences in the manuscript that showed high similarity index with other publications after the Duplicate Checking Process.

All the revised sentences in the manuscript have been made using the “Track Changes” function of MS Word.

Back to TopTop